Shopping multibaggers: Vijay Kedia buys Yatharth Hospital in September qtr, ups stake in this smallcap

Ace investor Vijay Kedia added multibagger Yatharth Hospital & Trauma Care Services to his portfolio during the September quarter, picking up 9.65 lakh shares, or 1% stake, in the Delhi-NCR-based hospital chain. He also raised his holding in another multibagger Global Vectra Helicorp, the country’s largest private helicopter operator during this period.

The shares were bought through his investment company Kedia Securities Private Limited.

Yatharth Hospital

Listed on August 7, 2023, shares of Yatharth Hospital have handsomely rewarded investors who bought its shares in the IPO. The stock has delivered 171% returns over the issue price of Rs 300. Its shares are currently trading around Rs 815 on the NSE.The stock is currently trading above its 50-day and 200-day simple moving averages (SMA) of Rs 749.1 and Rs 554.4 according to Trendlyne data. But the stock has been quite volatile with 1-year beta hovering around 1.2.

While the company is yet to announce its Q2 earnings, Yatharth Hospital’s consolidated June quarterly net profit stood at Rs 42 cr which was growth of 38% YoY. Total revenue in the said quarter stood at Rs 267 crore, which was growth of 24% YoY.
Also Read: Vijay Kedia buys on dips, acquires Rs 11 crore stake in smallcap company via bulk deal

Global Vectra

In Global Vectra, Kedia bought nearly 2.6 lakh shares representing 1.86% stake. He already held 3% equity accounting for 4.19 lakh shares in the company. His total holding stood at 4.86% as on September 30, 2025.
Unlike, Yatharth, additional share purchase by Kedia cames at a time when the stock has been on decline. Shares of Global Vectra are down 32% over a 1-year period but its 3-year returns are still of staggering 240%.

One of the most widely followed investors in India, Kedia’s portfolio consists of 15 stocks which are worth Rs 1,392.8 crore.

Also Read: Ashish Kacholia’s latest buy is an SME stock with 1,350% returns in 3 years. Check details

(Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.)